# Getinge Interim Report April-June 2026: Good organic growth, high profitability and strong cash flow

- Link: https://www.thailand-business-news.com/pr-news/getinge-interim-report-april-june-2026-good-organic-growth-high-profitability-and-strong-cash-flow
- Published: 2026-07-17T13:45:00+07:00
- Author: PR Newswire

GOTHENBURG, Sweden, July 17, 2026 /PRNewswire/ — 

**"We delivered a strong quarter both financially and operationally with several
important key achievements," says Mattias Perjos, President and CEO of Getinge.**

Sales in Acute Care Therapies increased in most product categories, and the positive
trend in consumables for life-supporting ECLS therapy was maintained. Surgical Workflows
continued to display good momentum. The situation in Life Science remains mixed –
the high-margin category of Sterile Transfer reported double-digit growth for both
its order intake and sales. However, the pharma sector’s willingness to invest remains
dominated by geopolitical uncertainty, which can primarily be seen in the project-
based and capital-intense product category of WIS.

The adjusted EBITA margin was 17.6%, positively impacted by a tariff refund of approximately
SEK 336 M, as well as by a continued positive underlying performance in the operations
featuring a favorable mix, continued price adaptations and productivity improvements–
which also led to a clear improvement in cash flow. Excluding the net effect of 
tariffs (SEK+244 M) and currency effects compared to last year (SEK -73 M), the 
adjusted EBITA margin was 15.2%.

Innovation focusing on customer value is vital, and Getinge launched several products
during the quarter that strengthen our offering. One example is a new product generation
within endoscopic vessel harvesting (EVH). In addition, a system for increased capacity
and enhanced safety in automated endoscope reprocessing was launched and a product
expanding the fluorescence imaging portfolio for small-incision surgery. A key regulatory
milestone was achieved alongside these launches when the 510(k)-application for 
the Cardiosave intra-aortic balloon pump was submitted to the FDA in June.

"We also strengthen our infection prevention offering in endoscopy by the acquisition
of Pennamed, a UK-based distributor of endoscopic consumables," says Mattias Perjos.

In addition, a new innovation center was opened in Hamburg that seeks to accelerate
the path to a more intelligent, digital perioperative workflow.

"Overall, we are well positioned in the prioritized product categories of our customers,
which gives us confidence for the future. While geopolitical uncertainty remains,
based on our regular dialogue with customers, we maintain our forecast of organic
sales growth of 3-5% in 2026," says Mattias Perjos.

**April-June 2026 in brief**

 ◦ Net sales increased organically by 4.6% (4.1) and the order intake rose by 6.2%
   organically (4.4)
 ◦ Adjusted gross profit amounted to SEK 4,645 M (4,183) and the margin was 55.4%(
   50.8)
 ◦ Adjusted EBITA was SEK 1,478 M (989) and the margin 17.6% (12.0)
 ◦ Adjusted earnings per share amounted to SEK 3.59 (2.25)
 ◦ Free cash flow amounted to SEK 1 001 M (510)

**January-June 2026 in brief**

 ◦ Net sales increased organically by 2.7% (5.1) and the order intake rose by 5.0%
   organically (3.6)
 ◦ Adjusted gross profit amounted to SEK 8,473 M (8,519) and the margin was 53.5%(
   51.5)
 ◦ Adjusted EBITA was SEK 2,302 M (1,992) and the margin 14.5% (12.0)
 ◦ Adjusted earnings per share amounted to SEK 5.39 (4.43)
 ◦ Free cash flow amounted to SEK 1 843 M (670)

**Phone Conference**

A conference call will be held on July 17, at 10.00-11.00 a.m. CEST hosted by Mattias
Perjos, President & CEO, and Agneta Palmér, CFO.

To participate via teleconference, please register via [this link](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4733816-1&h=1804692078&u=https%3A%2F%2Fevents.inderes.com%2Fgetinge%2Fq2-report-2026%2Fdial-in&a=this+link).
After registration, you will be provided with telephone numbers and a conference
ID to access the conference. You can ask questions verbally via the telephone conference.

During the conference call a presentation will be held. To access the presentation
through webcast, please use [this link](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4733816-1&h=2857047174&u=https%3A%2F%2Fgetinge.events.inderes.com%2Fq2-report-2026&a=this+link).
A recorded version can be accessed [here](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4733816-1&h=2557091980&u=https%3A%2F%2Fgetinge.events.inderes.com%2Fq2-report-2026&a=here)
for 3 years.

**Contact information:**

David Kördel, Head of Investor Relations
Phone: +46(0)10 335 0077E-mail: [david.kordel@getinge.com](https://www.thailand-business-news.com/pr-news/david.kordel@getinge.com)

_This information is such that Getinge AB is obliged to make public pursuant to 
the EU Market Abuse Regulation and the Swedish Securities Market Act. The information
was submitted for publication, through the agency of the contact person set out 
above, on July 17, 2026, at 08.00 CEST._

**About Getinge**

With a firm belief that every person and community should have access to the best
possible care, Getinge provides hospitals and life science institutions with products
and solutions that aim to improve clinical results and optimize workflows. The offering
includes products and solutions for intensive care, cardiovascular procedures, operating
rooms, sterile reprocessing and life science. Getinge employs approximately 12,000
people worldwide and the products are sold in more than 135 countries.

This information was brought to you by Cision [http://news.cision.com](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4733816-1&h=422445880&u=http%3A%2F%2Fnews.cision.com%2F&a=http%3A%2F%2Fnews.cision.com)

[https://news.cision.com/getinge/r/getinge-interim-report-april-june-2026–good-organic-growth–high-profitability-and-strong-cash-flow,c4375612](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4733816-1&h=3558151996&u=https%3A%2F%2Fnews.cision.com%2Fgetinge%2Fr%2Fgetinge-interim-report-april-june-2026--good-organic-growth--high-profitability-and-strong-cash-flow%2Cc4375612&a=https%3A%2F%2Fnews.cision.com%2Fgetinge%2Fr%2Fgetinge-interim-report-april-june-2026--good-organic-growth--high-profitability-and-strong-cash-flow%2Cc4375612)

The following files are available for download:

  |

[https://mb.cision.com/Main/942/4375612/4197347.pdf](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4733816-1&h=136074301&u=https%3A%2F%2Fmb.cision.com%2FMain%2F942%2F4375612%2F4197347.pdf&a=https%3A%2F%2Fmb.cision.com%2FMain%2F942%2F4375612%2F4197347.pdf)

  |

Getinge – Report Q2 2026

  |  
 |

[https://mb.cision.com/Public/942/4375612/84733ed2d9eaa383.pdf](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4733816-1&h=2273438840&u=https%3A%2F%2Fmb.cision.com%2FPublic%2F942%2F4375612%2F84733ed2d9eaa383.pdf&a=https%3A%2F%2Fmb.cision.com%2FPublic%2F942%2F4375612%2F84733ed2d9eaa383.pdf)

  |

Press release Getinge Interim Report Q2 2026

  |

 

---

  |  This article was produced by Cision PR Newswire, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not fully reflect the opinions of Thailand Business News. |

---

 
**Read the original article :** [Getinge Interim Report April-June 2026: Good organic growth, high profitability and strong cash flow ](http://www.prnasia.com/story/archive/5006867_AE06867_0?rand=184833)
